Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antenatal Treatment of Alloimmune Thrombocytopenia
NCT00194987Phase 3Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Apr 2001
- Primary completion
- Jun 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in Fetal and neonatal alloimmune thrombocytopenia (FNAIT), sponsored by Weill Cornell Medicine. Started Apr 2001; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Fetal and neonatal alloimmune thrombocytopenia (FNAIT)
Beyond the preview
Go deeper on NCT00194987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194987.